Analyst Price Target is $70.25
▲ +17.10% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $70.25, with a high forecast of $77.00 and a low forecast of $64.00. The average price target represents a 17.10% upside from the last price of $59.99.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in National Health Investors. This Hold consensus rating has held steady for over two years.
National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.